KP timeline
Every KP batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| KP-2608-D5921 | Tirzepatide | 20 Aug 2026 | 2026-Q3 | 13 | 98.91 | 1.47 | 99.52 | +0.61 | |
| KP-2607-H5219 | Retatrutide | 13 Jul 2026 | 2026-Q3 | 16 | 96.14 | 1.94 | 96.37 | +0.23 | |
| KP-2606-D5887 | Ipamorelin | 16 Jun 2026 | 2026-Q3 | 6 | 98.38 | 0.89 | 99.34 | +0.96 | |
| KP-2605-C4659 | TB-500 | 21 May 2026 | 2026-Q2 | 8 | 99.47 | 1.21 | 99.55 | +0.08 | |
| KP-2605-E6030 | Tirzepatide | 12 May 2026 | 2026-Q2 | 14 | 97.53 | 1.86 | 98.35 | +0.82 | |
| KP-2604-X5435 | Hexarelin | 30 Apr 2026 | 2026-Q2 | 10 | 98.55 | 1.24 | 99.00 | +0.45 | |
| KP-2604-N4308 | Retatrutide | 05 Apr 2026 | 2026-Q2 | 10 | 98.56 | 0.66 | 99.00 | +0.44 | |
| KP-2602-X5446 | Tirzepatide | 22 Feb 2026 | 2026-Q2 | 10 | 98.74 | 0.97 | 98.74 | 0.00 | |
| KP-2601-K4658 | Semaglutide | 05 Jan 2026 | 2026-Q2 | 5 | 98.13 | 0.94 | 98.76 | +0.63 | |
| KP-2512-U5139 | Desmopressin | 31 Dec 2025 | 2026-Q2 | 9 | 98.72 | 0.92 | 99.40 | +0.68 | |
| KP-2512-X4190 | Ipamorelin | 28 Dec 2025 | 2026-Q1 | 3 | 98.55 | 0.33 | 99.12 | +0.57 | |
| KP-2512-R5829 | Epitalon | 03 Dec 2025 | 2026-Q2 | 8 | 98.17 | 1.45 | 98.50 | +0.33 | |
| KP-2511-J4998 | Semaglutide | 23 Nov 2025 | 2026-Q2 | 13 | 99.86 | 0.92 | 99.90 | +0.04 | |
| KP-2511-W4792 | 5-Amino-1MQ | 22 Nov 2025 | 2026-Q2 | 5 | 99.33 | 0.62 | 99.00 | -0.33 | |
| KP-2511-W5336 | Exenatide | 15 Nov 2025 | 2026-Q1 | 2 | 98.01 | 0.33 | 98.38 | +0.37 | |
| KP-2511-M5346 | BPC-157 | 15 Nov 2025 | 2025-Q4 | 17 | 98.33 | 1.25 | 98.48 | +0.15 | |
| KP-2511-K4263 | Retatrutide | 11 Nov 2025 | 2026-Q1 | 9 | 97.12 | 1.02 | 97.46 | +0.34 | |
| KP-2510-V5596 | TB-500 | 17 Oct 2025 | 2025-Q4 | 4 | 98.90 | 0.84 | 99.50 | +0.60 | |
| KP-2509-N5148 | KPV | 22 Sep 2025 | 2025-Q4 | 12 | 99.09 | 0.85 | 99.49 | +0.40 | |
| KP-2509-J5482 | Semax | 17 Sep 2025 | 2026-Q1 | 10 | 99.70 | 1.05 | 99.41 | -0.29 | |
| KP-2508-Y5329 | Epitalon | 29 Aug 2025 | 2026-Q1 | 9 | 98.22 | 1.40 | 99.14 | +0.92 | |
| KP-2508-D4657 | N-Acetyl Semax Amide | 20 Aug 2025 | 2025-Q4 | 1 | 98.99 | n<2 | 98.63 | -0.36 | |
| KP-2508-J4716 | Melanotan II | 09 Aug 2025 | 2025-Q3 | 11 | 98.36 | 1.21 | 98.21 | -0.15 | |
| KP-2507-U6119 | N-Acetyl Semax Amide | 06 Jul 2025 | 2025-Q3 | 1 | 99.67 | n<2 | 99.39 | -0.28 | |
| KP-2506-B4700 | Tirzepatide | 05 Jun 2025 | 2025-Q4 | 6 | 97.85 | 0.56 | 97.93 | +0.08 | |
| KP-2506-L5639 | CJC-1295 with DAC | 03 Jun 2025 | 2025-Q3 | 4 | 99.43 | 0.94 | 99.90 | +0.47 | |
| KP-2505-F4869 | Tirzepatide | 18 May 2025 | 2025-Q4 | 5 | 96.73 | 0.44 | 97.28 | +0.55 | |
| KP-2504-V4847 | Tirzepatide | 11 Apr 2025 | 2025-Q3 | 7 | 98.16 | 0.95 | 98.45 | +0.29 | |
| KP-2503-L4599 | GHRP-6 | 15 Mar 2025 | 2025-Q3 | 4 | 98.44 | 0.73 | 99.00 | +0.56 | |
| KP-2502-C5740 | GHK-Cu | 26 Feb 2025 | 2025-Q3 | 5 | 98.68 | 0.85 | 98.65 | -0.03 | |
| KP-2502-H4693 | Semax | 18 Feb 2025 | 2025-Q2 | 8 | 98.85 | 1.03 | 99.40 | +0.55 | |
| KP-2502-E5076 | Liraglutide | 11 Feb 2025 | 2025-Q1 | 10 | 99.18 | 0.87 | 99.35 | +0.17 | |
| KP-2501-V5157 | Sermorelin | 08 Jan 2025 | 2025-Q1 | 12 | 98.85 | 1.08 | 98.89 | +0.04 | |
| KP-2501-G5777 | Pemvidutide | 05 Jan 2025 | 2025-Q1 | 1 | 96.91 | n<2 | 98.60 | +1.69 | |
| KP-2412-H4631 | TB-500 | 21 Dec 2024 | 2025-Q2 | 1 | 98.63 | n<2 | 99.49 | +0.86 | |
| KP-2411-Y4921 | CJC-1295 (no DAC) | 25 Nov 2024 | 2024-Q4 | 8 | 98.98 | 1.41 | 99.10 | +0.12 | |
| KP-2411-R5970 | BPC-157 | 04 Nov 2024 | 2025-Q2 | 6 | 98.59 | 1.03 | 98.89 | +0.30 | SHARED BULK |
| KP-2410-W6441 | Semaglutide | 08 Oct 2024 | 2025-Q1 | 11 | 97.58 | 1.35 | 98.50 | +0.92 | |
| KP-2409-Y5476 | NAD+ | 30 Sep 2024 | 2024-Q4 | 3 | 99.18 | 0.88 | 99.73 | +0.55 | |
| KP-2409-N5350 | Ipamorelin | 21 Sep 2024 | 2024-Q4 | 4 | 99.18 | 0.45 | 99.01 | -0.17 | |
| KP-2408-H6177 | SS-31 (Elamipretide) | 23 Aug 2024 | 2025-Q1 | 6 | 98.81 | 1.30 | 99.64 | +0.83 | |
| KP-2408-L4018 | MK-677 (Ibutamoren mesylate) | 14 Aug 2024 | 2024-Q3 | 1 | 99.88 | n<2 | 99.81 | -0.07 | |
| KP-2407-T4233 | Tirzepatide | 29 Jul 2024 | 2024-Q3 | 1 | 97.47 | n<2 | 98.50 | +1.03 | |
| KP-2407-L4230 | BPC-157 | 27 Jul 2024 | 2024-Q4 | 11 | 98.77 | 0.88 | 98.89 | +0.12 | |
| KP-2407-H5949 | Ipamorelin | 26 Jul 2024 | 2024-Q3 | 7 | 99.92 | 0.52 | 100.50 | +0.58 | |
| KP-2407-W4507 | N-Acetyl Semax Amide | 24 Jul 2024 | 2024-Q4 | 1 | 97.78 | n<2 | 98.82 | +1.04 | |
| KP-2407-V5560 | TB-500 | 23 Jul 2024 | 2024-Q4 | 1 | 98.92 | n<2 | 99.65 | +0.73 | |
| KP-2406-K4745 | IGF-1 LR3 | 20 Jun 2024 | 2024-Q3 | 1 | 97.51 | n<2 | 98.09 | +0.58 | |
| KP-2406-P6131 | Semaglutide | 11 Jun 2024 | 2024-Q4 | 9 | 98.04 | 1.74 | 98.24 | +0.20 | |
| KP-2405-H5398 | Selank | 11 May 2024 | 2024-Q3 | 12 | 97.86 | 0.98 | 98.19 | +0.33 | |
| KP-2405-C4384 | Semaglutide | 03 May 2024 | 2024-Q3 | 3 | 97.34 | 0.54 | 98.26 | +0.92 | |
| KP-2312-R4578 | Sermorelin | 20 Dec 2023 | 2024-Q2 | 10 | 99.25 | 1.29 | 99.06 | -0.19 |